Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

NCT06045299 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Corxel Pharmaceuticals

Collaborators